NCT01169532 2021-02-21
Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma
Fox Chase Cancer Center
Phase 1 Completed
Clinical Trials
6 trialsNCT01212627 2021-02-16
Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer
Brown University
Phase 1 Terminated
NCT00874731 2019-05-06
MK-8669-037
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01380184 2019-04-19
MK-8669-059
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT01431534 2019-03-01
MK-8669-056
Merck Sharp & Dohme LLC
Phase 1 Terminated
NCT01243762 2018-08-16
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
Merck Sharp & Dohme LLC
Phase 1 Terminated